abstract |
The invention relates to immunology and immunotherapy applications using oligonucleotides as immunostimulatory agents. In particular, the invention relates to immunostimulatory oligonucleotide immunomers, immunomodulatory compositions comprising said immunomodulatory oligonucleotide immunomers, and the use of said immunomodulatory oligonucleotide immunomers for immunotherapy applications. |